Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

DIBUCAINE OINTMENT

Active
SPE2DP-27-T-0233Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

UNIT 100496 BOX 1, FPO, AP, 96678, USA

Set-Aside

NONE

Documents

1
PDF

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
DIBUCAINE OINTMENT
DIBUCAINE OINTMENT<(>,<)> USP. CONTAINS 1 PERCENT OF DIBUCAINE OINTMENT
AS THE ACTIVE INGREDIENT. COMES SUPPLIED IN A COLLAPSIBLE TUBE AND
RECTAL APPLICATOR. RECTALLY ADMINISTERED. FOR EXTERNAL USE ONLY. UNIT OF
ISSUE IS A PACKAGE CONTAINING ONE (1) OUNCE OR 28 GRAMS. STORE AT 15-30
DEGREES CELSIUS OR 59 TO 86 DEGREES FARENHEIT.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
THE HARVARD DRUG GROUP, L.L.C. 1LEZ0 P/N NDC00536-1211-95
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018973414 0001 PG 1.000
NSN/MATERIAL:6505002999535
DELIVERY (IN DAYS):0020
SPE2DP-27-T-0233
SECTION B
PR: 7018973414 PRLI: 0001 CONT’D
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
N21468
USNS SALVOR T ARS 52
UNIT 100496 BOX 1
FPO AP 96678
US
RDD 777 SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
N21468
USNS SALVOR ARS 52
DLA VENDORS: USE VSM FOR
US
M/F: (TCN) N214686306S106
RDD: 777
PROJ: HP5 TP 2
SUPP ADD: YDRUG SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A41 DIST: 9B ADV: 2A FC: E5
Need Ship Date:00/00/0000 Original Required Delivery Date:11/05/2026
SPE2DP-27-T-0233 NSN/Part Number: 6505-00-299-9535 Quantity: 1 PG Purchase Request: 7018973414QTY: 1 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
SODIUM PERBORATE
Solicitation # SPE2DP-27-T-0229
Solicitation SPE2DP-27-T-0229 is a procurement by the Defense Logistics Agency for one 100 gram bottle of Sodium Perborate in powder form, identified by NSN 6505-01-307-3268. The item is a regulated FDA drug or device and is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Strict storage requirements apply, including avoiding high humidity and maintaining temperatures below 32 degrees Celsius (90 degrees Fahrenheit), while keeping the material away from flammable or combustible substances. Delivery is required within 20 days after receipt of order, with a destination FOB and a required delivery date of August 6, 2026, for shipment to the USS Portland LPD 27 via DLA Distribution San Diego. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for material marking. Packaging must comply with DLA Packaging Requirements for Procurement (RP001) and ASTM D3951 for non-hazardous materials, though TQ requirement IP025 and FED-STD-313 apply if the material is deemed hazardous. Inspection and acceptance will occur at the destination per FAR 52.246-2. The procurement incorporates various federal and defense clauses, including the Buy American Act, DFARS cybersecurity reporting requirements, and the DLA Master List of Technical and Quality Requirements. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 2 hours ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 423450
New
DIBBS
ATROPINE SULFATE IN
Solicitation # SPE2DP-27-T-0231
This procurement, issued by DLA Troop Support Medical Supply Chain Pharm FSA under solicitation SPE2DP-27-T-0231, is for the supply of Atropine Sulfate Injection, USP (NSN 6505-01-573-1657). The required product is a sterile, nonpyrogenic, preservative-free, and non-DEHP injection with a concentration of 0.1 mg/ml and a total content of 0.5 mg per 5 ml. Each milliliter must contain 0.1 mg of atropine sulfate monohydrate and 9 mg of sodium chloride. The item has a non-extendable shelf life of 24 months and must be stored at a controlled room temperature between 20°C and 25°C. The contract consists of multiple line items with varying quantities, including 6 PG for CLIN 0001 and 0009, 3 PG for CLIN 0005, and 2 PG for CLIN 0003 and 0010. Delivery is set as FOB Destination to Fort Bragg, NC, with various required delivery dates ranging from March to July 2026. Packaging must comply with MIL-STD-129 for marking and labeling, RP001 for palletization, and either ASTM D3951 for non-hazardous materials or TQ Requirement IP025 for hazardous materials. Inspection and acceptance will occur at the destination per FAR 52.246-2. Key regulatory and administrative requirements include compliance with the Buy American and Balance of Payments Program (DFARS 252.225-7001) and the safeguarding of covered defense information (DFARS 252.204-7012). Invoicing must be processed electronically through the Wide Area WorkFlow (WAWF) system. The solicitation is open for quotations until November 9, 2026, and is categorized under NAICS code 423450.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 2 hours ago

DEADLINE

in 6 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS